A 21-gene RT-PCR assay in lymph node negative (LN-), estrogen receptor positive (ER+) early-stage breast cancer (ESBC): an age-specific economic analysis.
Publication
, Conference
Lyman, GH; Cosler, LE; Hornberger, J
Published in: BREAST CANCER RESEARCH AND TREATMENT
2004
Duke Scholars
Published In
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Publication Date
2004
Volume
88
Start / End Page
S103 / S104
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., Cosler, L. E., & Hornberger, J. (2004). A 21-gene RT-PCR assay in lymph node negative (LN-), estrogen receptor positive (ER+) early-stage breast cancer (ESBC): an age-specific economic analysis. In BREAST CANCER RESEARCH AND TREATMENT (Vol. 88, pp. S103–S104).
Lyman, G. H., L. E. Cosler, and J. Hornberger. “A 21-gene RT-PCR assay in lymph node negative (LN-), estrogen receptor positive (ER+) early-stage breast cancer (ESBC): an age-specific economic analysis.” In BREAST CANCER RESEARCH AND TREATMENT, 88:S103–4, 2004.
Lyman GH, Cosler LE, Hornberger J. A 21-gene RT-PCR assay in lymph node negative (LN-), estrogen receptor positive (ER+) early-stage breast cancer (ESBC): an age-specific economic analysis. In: BREAST CANCER RESEARCH AND TREATMENT. 2004. p. S103–4.
Lyman, G. H., et al. “A 21-gene RT-PCR assay in lymph node negative (LN-), estrogen receptor positive (ER+) early-stage breast cancer (ESBC): an age-specific economic analysis.” BREAST CANCER RESEARCH AND TREATMENT, vol. 88, 2004, pp. S103–04.
Lyman GH, Cosler LE, Hornberger J. A 21-gene RT-PCR assay in lymph node negative (LN-), estrogen receptor positive (ER+) early-stage breast cancer (ESBC): an age-specific economic analysis. BREAST CANCER RESEARCH AND TREATMENT. 2004. p. S103–S104.
Published In
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Publication Date
2004
Volume
88
Start / End Page
S103 / S104
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences